Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

This study has been completed.
National Cancer Institute (NCI)
Beth Israel Deaconess Medical Center
Information provided by:
Roger Williams Medical Center Identifier:
First received: November 1, 1999
Last updated: June 9, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2003
  Primary Completion Date: September 2003 (Final data collection date for primary outcome measure)